Axberg I - Search Results

1

Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.

Landegren U, Ramstedt U, Axberg I, Ullberg M, Jondal M, Wigzell H. Landegren U, et al. Among authors: axberg i. J Exp Med. 1982 May 1;155(5):1579-84. doi: 10.1084/jem.155.5.1579. J Exp Med. 1982. PMID: 6978378 Free PMC article.

2

Inhibition of natural killer cell cytotoxicity by a monoclonal antibody directed against adhesion-mediating protein gp 90 (CD18).

Axberg I, Ramstedt U, Patarroyo M, Beatty P, Wigzell H. Axberg I, et al. Scand J Immunol. 1987 Nov;26(5):547-54. doi: 10.1111/j.1365-3083.1987.tb02288.x. Scand J Immunol. 1987. PMID: 2961052

3

Cyclosporin a permits the distinction between specific T and NK activity generated in a human MLC.

Landegren U, Ramstedt U, Axberg I, Orn A, Wigzell H. Landegren U, et al. Among authors: axberg i. Int J Cancer. 1981 Dec;28(6):725-30. doi: 10.1002/ijc.2910280611. Int J Cancer. 1981. PMID: 6174458

4

Natural killer cells do not belong to the recirculating lymphocyte population.

Zöller M, Bellgrau D, Axberg I, Wigzell H. Zöller M, et al. Among authors: axberg i. Scand J Immunol. 1982 Feb;15(2):159-67. doi: 10.1111/j.1365-3083.1982.tb00634.x. Scand J Immunol. 1982. PMID: 6179152

5

The effect of tunicamycin on target cell susceptibility to natural killer cell cytotoxicity.

Nose M, Gidlund M, Hosein Z, Axberg I, Wigzell H, Yogeeswaran G. Nose M, et al. Among authors: axberg i. Scand J Immunol. 1987 Feb;25(2):149-57. doi: 10.1111/j.1365-3083.1987.tb01058.x. Scand J Immunol. 1987. PMID: 3469745

6

Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.

Une C, Grönberg A, Axberg I, Jondal M, Orn A. Une C, et al. Among authors: axberg i. Cell Immunol. 1991 Mar;133(1):127-37. doi: 10.1016/0008-8749(91)90185-e. Cell Immunol. 1991. PMID: 1703925

7

Decreased natural killer (NK) susceptibility of human NK target cells after phosphatidylinositol-specific phospholipase C treatment.

Uggla C, Une C, Axberg I, Jondal M, Knowles RW, Orn A. Uggla C, et al. Among authors: axberg i. Scand J Immunol. 1989 Jan;29(1):83-9. doi: 10.1111/j.1365-3083.1989.tb01102.x. Scand J Immunol. 1989. PMID: 2537997

8

Features of the in vitro established rat large granular lymphocyte leukaemia RNK-16.

Axberg I, Nose M, Reynolds CW, Wigzell H. Axberg I, et al. Scand J Immunol. 1988 Mar;27(3):271-8. doi: 10.1111/j.1365-3083.1988.tb02347.x. Scand J Immunol. 1988. PMID: 3353687

9

Natural killer activity in (C57BL/6 X DBA/2)F1 hybrids undergoing acute and chronic graft-vs.-host reaction.

Pattengale PK, Ramstedt U, Gidlund M, Orn A, Axberg I, Wigzell H. Pattengale PK, et al. Among authors: axberg i. Eur J Immunol. 1983 Nov;13(11):912-9. doi: 10.1002/eji.1830131110. Eur J Immunol. 1983. PMID: 6641788

10

Pigment mutations in the mouse which also affect lysosomal functions lead to suppressed natural killer cell activity.

Orn A, Håkansson EM, Gidlund M, Ramstedt U, Axberg I, Wigzell H, Lundin LG. Orn A, et al. Among authors: axberg i. Scand J Immunol. 1982 Mar;15(3):305-10. doi: 10.1111/j.1365-3083.1982.tb00653.x. Scand J Immunol. 1982. PMID: 7089489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters